Terumo (OTCMKTS:TRUMY) Shares Gap Down – Should You Sell?

Terumo Corp. (OTCMKTS:TRUMY)’s stock price gapped down prior to trading on Friday . The stock had previously closed at $14.68, but opened at $14.1101. Terumo shares last traded at $14.6050, with a volume of 4,997 shares changing hands.

Terumo Stock Down 0.3%

The firm’s 50 day moving average is $15.57 and its two-hundred day moving average is $16.76. The company has a current ratio of 2.51, a quick ratio of 1.46 and a debt-to-equity ratio of 0.07. The firm has a market cap of $21.68 billion, a P/E ratio of 24.40 and a beta of 0.75.

Terumo (OTCMKTS:TRUMY) last posted its quarterly earnings results on Wednesday, November 12th. The company reported $0.16 earnings per share (EPS) for the quarter, hitting the consensus estimate of $0.16. Terumo had a net margin of 12.35% and a return on equity of 9.39%. The business had revenue of $1.86 billion for the quarter, compared to analyst estimates of $1.75 billion.

Terumo Company Profile

Terumo Corporation (OTCMKTS: TRUMY) is a Japan-based medical technology company that develops, manufactures and markets a broad range of healthcare products for hospitals, clinics and blood centers. Its businesses encompass cardiovascular systems, general hospital products and blood management and cell technologies, supplying devices used in interventional and surgical procedures as well as everyday clinical care. Terumo sells consumables and capital equipment intended to support patient care across acute and ambulatory settings.

Key product categories include vascular access and interventional devices (such as guidewires, catheters and delivery systems), cardiac and cardiopulmonary surgical equipment, infusion therapy products (including infusion pumps and disposables), syringes and blood bags.